150
Participants
Start Date
June 4, 2025
Primary Completion Date
June 1, 2026
Study Completion Date
December 31, 2026
Eszopiclone 3 mg
Eszopiclone is an FDA-approved treatment for insomnia in those who have difficulty falling asleep and for patients with difficulty staying asleep (sleep maintenance).
Placebo
Placebo pills identical to the active comparator.
RECRUITING
Academic Research Organization - Heart Institute (InCor), São Paulo
Collaborators (1)
Eurofarma Laboratorios S.A.
INDUSTRY
University of Sao Paulo
OTHER